AstraZeneca Pharma India Limited's total assets for Q3 2025 were ₹0.00, a decrease of -100.00% from the previous quarter. IN:ASTRAZEN total liabilities were ₹-6.79B for the fiscal quarter, a -220.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.